A Case of Prostatic Metastasis from Intrahepatic Cholangiocarcinoma: An Extremely Rare Event

• Published in: Curēus (Palo Alto, CA) Vol. 15; no. 2; p. e35100
• Main Authors: Aiyadurai, Sanathan, Garg, Tulika, Sayeed, Tass, Shahbaz, Zainab, Adewole, Idowu O, Nguty Nkeng, Enoh, Joseph, Abia, Udoeyop, Datiobong, Qamar, Yusra, Khan, Aadil
• Format: Journal Article
• Language: English
• Published: United States Cureus Inc 17.02.2023; Cureus
• Subjects: Abdomen; Angiogenesis; Cancer therapies; Case reports; Chemotherapy; Cholangiocarcinoma; Gallbladder; General Surgery; Growth factors; Histopathology; Hospitals; Internal medicine; Lajpat Rai, Lala; Liver; Lymphatic system; Magnetic resonance imaging; Medical prognosis; Medicine; Metastasis; Mortality; Oncology; Patients; Prostate; Prostate cancer; Radiation therapy; Surgery; Tomography; Tumors; Urology; United States > US; Chicago Illinois; lymphangiogenesis; chemoradiotherapy; intrahepatic cholangiocarcinoma (icc); prostate cancer; metastasis
• ISSN: 2168-8184; 2168-8184
• DOI: 10.7759/cureus.35100

The second most frequent primary carcinoma of the liver to emerge is intrahepatic cholangiocarcinoma (ICC), which is thought to be an incurable, rapidly proliferating tumor with a dismal prognosis. ICC is typically found at an advanced stage and is physiologically hostile. Regional lymph nodes and liver metastases are frequent tumor metastatic sites for ICC and serve as indicators of tumor recurrence. ICC metastasizing to the male urogenital tract has only seldom been documented. Typically, lymph vessels serve as the primary pathway for disseminating tumor cells. The high fatality rate associated with ICC and the rapid spread of the disease may be caused by this lymphatic route. The only curative therapeutic approach for treating these tumors is surgical removal. We report a case of prostatic metastasis from ICC.